Pfizer/BioNTech’s Phase 4 real-world effectiveness study of BNT162b2 in U.S. healthcare workers, first responders, and other essential frontline workers, plus their household contacts. Run alongside the pivotal C4591001 trial to capture vaccine effectiveness in higher-exposure occupations and to characterize SARS-CoV-2 transmission dynamics within households of vaccinated participants.
Latest protocol we have: 019736_S222_M5_c4591020-protocol.pdf
| Category | Count | Amendments |
|---|---|---|
| Total documents in the history | 1 | |
| Direct PDFs available | 1 | Original protocol |
| Summary-only (date and rationale recorded here, no full PDF available) | 0 | (none) |
| Document | Version Date | Available documents | Summary and Rationale for Changes |
|---|---|---|---|
| Original protocol | 18 Jan 2021 | 019736_S222_M5_c4591020-protocol.pdfPHMPT individual | N/A |